Words To Assure Protection for Whistleblowers Can Evoke Fear
New study finds that vivid language intended to assure potential whistleblowers they will be protected from retaliation is instead likely to evoke fear and make them less likely to report misconduct.
麻豆精品视频Jupiter's LLS Awards $11,000 in Scholarships
麻豆精品视频Jupiter's LLS awarded 11 scholarships to undergraduate and graduate students.
麻豆精品视频Wave Competition Announces Winners
麻豆精品视频's Division of Research recently hosted a celebratory event for the inaugural 麻豆精品视频Wave Competition, an undergraduate research and entrepreneurial contest.
Senator Joe Negron Visits FAU's College of Business
Florida's incoming Senate President Joe Negron visited 麻豆精品视频's College of Business on the last day of his four-day tour of the state university system.
麻豆精品视频Hosts First U.S. Clinical Trial for Lewy Body Dementia
There are currently no medications available to specifically treat Lewy Body dementia (LBD). FAU's College of Medicine is spearheading the South Florida site for the first U.S. clinical trial for LBD.
麻豆精品视频Preschoolers to Rally for Earth Day
Preschool students from FAU's Karen Slattery Educational Research Center for Child Development will stage their support for the environment as part of FAU's annual Earth Day celebration.
Steven D. Roper Named Founding Executive Director
Steven D. Roper, Ph.D., has been appointed as the founding executive director of the Peace, Justice and Human Rights Initiative at 麻豆精品视频.
麻豆精品视频Hosts 47th Annual Honors Convocation
麻豆精品视频 President John Kelly and Provost Gary W. Perry will host the University's 47th annual Honors Convocation on Wednesday, April 20.
MPFI Scholar Earns Top Spot in Competition
Five 麻豆精品视频students participating in the MPFI Scholars program showcased research at the Symposium for Young Neuroscientists and Professors of the Southeast (SYNAPSE) in Clinton, S.C.
Researcher Receives NIH Grant for MS and Cancer Treatment
A leading scientist has received $540,250 from the NIH to continue his groundbreaking research to develop new therapeutic agents for collagen-based diseases including multiple sclerosis, cancer and sepsis.